Leading investors warn that the sharemarket's ascent to the 7000 points level helped by the lowest interest rates in history should be met with caution and may not be supported by earnings in an economy growing below-trend.
A formalised phase one trade deal between the US and China pushed the Australian market to a record 7041.8 on Thursday and biotech champion CSL to an all-time high of $300.89.
Loading...
Sarah Turner was Perspective editor at The Australian Financial Review.
Vesna Poljak was The Australian Financial Review’s companies editor.